Salesforce Friends ...
Health Care: Drugs
Dendreon Corp (DNDN: NASDAQ)
$5.91 -0.85 | -12.57%
06/04/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 341.61M | 48.06M | 101.00K | 111.00K |
| Cost of Sales | 96.87M | 10.90M | -5.31M | -5.72M |
| Gross Operating Profit | 244.75M | 37.16M | 5.41M | 5.83M |
| Selling, General, and Administrative Expenses | 361.34M | 235.76M | 38.56M | 20.50M |
| Research & Development | 74.29M | 75.94M | 61.59M | 50.09M |
| Operating Income before D & A (EBITDA) | -190.89M | -274.54M | -94.73M | -64.76M |
| Depreciation & Amortization | 62.22M | 17.62M | 5.31M | 5.72M |
| Interest Income | 1.42M | 1.14M | 964.00K | 3.62M |
| Other Income - Net | 180.00K | -147.28M | -118.76M | 371.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -290.10M | -438.30M | -217.84M | -66.49M |
| Interest Expense | 47.70M | 1.59M | 2.32M | 5.16M |
| Pre-Tax Income | -337.81M | -439.89M | -220.16M | -71.64M |
| Income Taxes | 0.00 | -411.00K | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -337.81M | -439.48M | -220.16M | -71.64M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -337.81M | -439.48M | -220.16M | -71.64M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -337.81M | -439.48M | -220.16M | -71.64M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-299.22M | -439.48M | -220.16M | -71.64M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -337.81M | -439.48M | -220.16M | -71.64M |
| Basic EPS from Continuing Ops. | -2.31 | -3.18 | -2.04 | -0.79 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -2.31 | -3.18 | -2.04 | -0.79 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -2.31 | -3.18 | -2.04 | -0.79 |
| Basic Normalized Net Income/Share | -2.05 | -3.18 | -2.04 | -0.79 |
| EPS fr Continuing Ops. | -2.31 | -3.18 | -2.04 | -0.79 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -2.31 | -3.18 | -2.04 | -0.79 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -2.31 | -3.18 | -2.04 | -0.79 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-2.05 | -3.18 | -2.04 | -0.79 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with DNDN
- Portfolio NameUser Type
- UserLong Term Stock Picks
- UserTop 10 Small Cap Stock Picks
- ContributorBreakout Stocks Of The Week...
- UserS ACCT
- UserRISK
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorRelative Strength Trades fo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
Latest DNDN Headlines from TheStreet
- Dendreon Stock Hits New 52-Week Low (DNDN) 06.04.12 | 10:06 am
- ASCO 2012 Live Blog -- Monday 06.04.12 | 06:06 am
- ASCO '12 Stocks: Winners and Losers 06.04.12 | 06:06 am
- ASCO 2012 Live Blog -- Saturday 06.02.12 | 07:06 am
- J&J Scores Big With Prostate Cancer Pill 06.02.12 | 12:06 am
- Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer 05.25.12 | 05:05 am
- The Next Big Thing in Biotech: ASCO Conference
05.25.12 | 05:05 am - Dendreon Management Presents At Bank Of America Merrill Lynch 2012 Health Care Conference (Transcript) 05.17.12 | 01:05 am
- Dendreon Management Presents At Deutsche Bank Securities, Inc. 37th Annual Health Care Conference (Transcript) 05.11.12 | 07:05 pm
- Dendreon Stock Gaps Down On Today's Open (DNDN) 05.08.12 | 08:05 am
Press Releases for DNDN
- Dendreon Announces Webcast Presentations At Upcoming Conferences - Business Wire 05.25.12 | 08:05 pm
- Dendreon Announces Data Presentation At The 2012 American Urological Association Annual Meeting - Business Wire 05.21.12 | 10:05 am
- Dendreon Announces Presentation Of PROVENGE Data At The 2012 American Society Of Clinical Oncology Annual Meeting - Business Wire 05.16.12 | 06:05 pm
- Dendreon Reports Net PROVENGE Product Revenues Of $82 Million, Achieved 6.5% Quarter-Over-Quarter Growth - Business Wire 05.07.12 | 04:05 pm
- Jennerex Elects Dr. Mitchell H. Gold To Board Of Directors - PR Newswire 04.17.12 | 07:04 am
- Dendreon To Host Conference Call On May 7 To Announce First Quarter Financial Results And Webcast Presentations At Upcoming Conferences - Business Wire 04.09.12 | 05:04 pm
- Genesis Biopharma Names Biotech Industry Veteran Hans E. Bishop As Executive Chairman Of The Board - PR Newswire 03.22.12 | 08:03 am
- Dendreon Announces Webcast Presentation At Upcoming Conferences - Business Wire 03.05.12 | 08:03 am
- Dendreon Announces Executive Appointments - Business Wire 02.28.12 | 05:02 pm
- Dendreon Reports Fourth Quarter And 2011 Year End Financial Results - Business Wire 02.27.12 | 08:02 am
Partner Headlines for DNDN
- Analyst Alerts: General Motors, Valero, Copa Holdings, Dendreon June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- Active Stock Alerts: Dendreon, Delcath Systems, Johnson & Johnson, Boeing, Onyx June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- Stock Insights: Dendreon, Medtronic, FedEx, ArQule, Rentrak June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- Social Media Outlook for Monday June 4 (AUXL, NFLX, DNDN, IBM) - Benzinga 06.04.12 | 09:06 am
- Healthcare Business Recap: Dendreon BOMBS, Cancer Cures Galore - Wall St. Cheat Sheet 06.04.12 | 06:06 am
- J&J and 2 Dow 30 Stocks BUZZING Now - Wall St. Cheat Sheet 06.04.12 | 04:06 am
- 3 BOMBS Getting Dropped on Dendreon Now - Wall St. Cheat Sheet 06.04.12 | 03:06 am
- Baxter And Neostem Validating Each Other's Cell Therapies - Seeking Alpha 06.01.12 | 09:06 am
- IsoRay: A Potential Small-Cap Bio-Pharma Multi-Bagger - Seeking Alpha 05.29.12 | 09:05 am
- Analyst Alerts: VeriFone, Dendreon, TD Bank May 25th - Wall St. Cheat Sheet 05.25.12 | 11:05 am
